Trastuzumab

Tax included
Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
MedChemExpress 
HY-P9907

Data sheet

Size
Multiple sizes
Reactivity
EGFR; ADC Antibody
Application
Cancer-Kinase/protease
CAS
180288-69-1